Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials
Abstract Background The benefits and risks of anti-acid medication in patients with idiopathic pulmonary fibrosis (IPF) remain a topic of debate. We investigated whether use of anti-acid medication at baseline was associated with differences in the natural course of disease or influenced the treatme...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-09-01
|
| Series: | Respiratory Research |
| Online Access: | http://link.springer.com/article/10.1186/s12931-018-0866-0 |